Roche's MS Drug Ocrelizumab Shows Promising Results After Late Stage Trials

Roche Holdings announced that their newest MS drug was able to treat the disease effectively according to the findings of their clinical trials. Hope for progress in MS treatment is made anew with the drug's success.